首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >PREFERENTIAL INDUCTION OF A TH-1 IMMUNE RESPONSE AND INHIBITION OF SPECIFIC IGE ANTIBODY FORMATION BY PLASMID DNA IMMUNIZATION
【24h】

PREFERENTIAL INDUCTION OF A TH-1 IMMUNE RESPONSE AND INHIBITION OF SPECIFIC IGE ANTIBODY FORMATION BY PLASMID DNA IMMUNIZATION

机译:优先诱导TH-1免疫反应和通过质粒DNA免疫抑制特异性Ige抗体形成

获取原文
获取原文并翻译 | 示例
       

摘要

We compared the antigen-specific antibody isotypes and lymphokine secretion by CD4(+) T cells in BALB/c mice immunized intradermally with either Escherichia coli beta-galactosidase (beta-gal) or plasmid DNA (pDNA) encoding beta-gal in a cytomegalovirus-based expression vector (pCMV-LacZ). pCMV-LacZ induced mainly IgG2a, whereas beta-gal in saline or alum induced IgG1 and IgE beta-gal-specific antibodies. In addition, splenic CD4(+) T helper (Th) cells isolated from pDNA-immunized mice secreted interferon-gamma but not interleukin (IL)-4 and IL-5, whereas Th cells from beta-gal-injected mice secreted IL-4 and IL-5 but not interferon-gamma after in vitro stimulation with antigen. Together these data demonstrate that pDNA immunization induced a T helper type 1 (Th-1) response, whereas protein immunization induced a T helper type 2 (Th-2) response to the same antigen. Interestingly, priming of mice with pCMV-LacZ prevented IgE antibody formation to a subsequent i.p. beta-gal in alum injection. This effect was antigen-specific, because priming with pCMV-LacZ did not inhibit IgE anti-ovalbumin antibody formation. Most importantly, intradermal immunization with pCMV-LacZ (but not pCMV-OVA) of beta-gal in alum-primed mice caused a 66-75% reduction of the IgE anti-beta-gal titer in 6 weeks. Also, pCMV-LacZ induced specific IgG2a antibody titers and interferon-gamma secretion by Th cells in the beta-gal in alum-primed mice. The data demonstrate that gene immunization induces a Th-1 response that dominates over an ongoing protein-induced Th-2 response in an antigen-specific manner. This suggests that immunization with pDNA encoding for allergens may provide a novel type of immunotherapy for allergic diseases. [References: 29]
机译:我们比较了抗原β-半乳糖苷酶(β-gal)或编码巨细胞病毒中β-gal的质粒DNA(pDNA)真皮内免疫接种的BALB / c小鼠的抗原特异性抗体同种型和CD4(+)T细胞的淋巴因子分泌的表达载体(pCMV-LacZ)。 pCMV-LacZ主要诱导IgG2a,而盐水或明矾中的β-gal诱导IgG1和IgEβ-gal特异性抗体。此外,从经pDNA免疫的小鼠中分离得到的脾CD4(+)T辅助(Th)细胞分泌干扰素-γ,但不分泌白介素(IL)-4和IL-5,而注射β-gal的小鼠Th细胞分泌IL--4。 4和IL-5,但在体外用抗原刺激后没有干扰素-γ。这些数据一起证明,pDNA免疫诱导了对同一抗原的1型T辅助反应(Th-1),而蛋白质免疫诱导了对相同抗原的2型T辅助反应(Th-2)。有趣的是,用pCMV-LacZ引发小鼠阻止了IgE抗体形成至随后的腹膜内。明矾注射液中的β-gal。该作用是抗原特异性的,因为用pCMV-LacZ引发不会抑制IgE抗卵清蛋白抗体的形成。最重要的是,在明矾引发的小鼠中,使用pCMV-LacZ(而非pCMV-OVA)的β-gal皮内免疫可在6周内使IgE抗β-gal滴度降低66-75%。同样,pCMV-LacZ在明矾引发的小鼠中诱导特异性的IgG2a抗体滴度和Th细胞在β-gal中的干扰素-γ分泌。数据表明,基因免疫以抗原特异性方式诱导Th-1反应,该反应胜过正在进行的蛋白诱导的Th-2反应。这表明用编码过敏原的pDNA进行免疫可能为过敏性疾病提供一种新型的免疫疗法。 [参考:29]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号